Five Priority Areas for Improving Medications Development for Alcohol Use Disorder and Promoting Their Routine Use in Clinical Practice-Reference-Cited by-同舟云学术

Five Priority Areas for Improving Medications Development for Alcohol Use Disorder and Promoting Their Routine Use in Clinical Practice

Published:2019-12-05 Issue:1 Volume:44 Page:23-35
ISSN:0145-6008
Container-title:Alcoholism: Clinical and Experimental Research
language:en
Short-container-title:Alcohol Clin Exp Res

Author:

Litten Raye Z.¹^ORCID,Falk Daniel E.¹^ORCID,Ryan Megan L.¹,Fertig Joanne¹,Leggio Lorenzo²³⁴^ORCID

Affiliation:

1. National Institute on Alcohol Abuse and Alcoholism Bethesda Maryland

2. Section on Clinical Psychoneuroendocrinology and Neuropsychopharmacology National Institute on Alcohol Abuse and Alcoholism and National Institute on Drug Abuse National Institutes of Health Bethesda Maryland

3. Medication Development Program National Institute on Drug Abuse National Institutes of Health Baltimore Maryland

4. Center for Alcohol and Addiction Studies Brown University Providence Rhode Island

Publisher

Wiley

Subject

Psychiatry and Mental health,Toxicology,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/acer.14233

Reference131 articles.

1. Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study

2. Baclofen for the treatment of alcohol use disorder: the Cagliari Statement

3. Medications for alcohol use disorders: An overview

4. An Evaluation of μ-Opioid Receptor (OPRM1) as a Predictor of Naltrexone Response in the Treatment of Alcohol Dependence

5. Aripiprazole Suppression of Drinking in a Clinical Laboratory Paradigm: Influence of Impulsivity and Self-Control

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medication development for AUD: A systematic review of clinical trial methodology;Alcohol;2024-11

2. IL17RB genetic variants are associated with acamprosate treatment response in patients with alcohol use disorder: A proteomics-informed genomics study;Brain, Behavior, and Immunity;2024-08

3. Naltrexone augmented with prazosin for alcohol use disorder: results from a randomized controlled proof-of-concept trial;Alcohol and Alcoholism;2024-07-21

4. Leveraging meta-regression to test if medication effects on cue-induced craving are associated with clinical efficacy;Psychopharmacology;2024-04-13

5. Prefrontal Electrophysiological Biomarkers and Mechanism-Based Drug Effects in a Rat Model of Alcohol Addiction;2024-02-22